Taili Biotechnology (Shanghai) Co., Ltd.
泰励生物
Taili Biotechnology (Shanghai) Co., Ltd.
Biotech/Healthcare
Founded in 2018, Tyligand Bioscience (Shanghai) Co., Ltd. develops immuno-oncology therapies.
Latest round: Series A Extension (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-07-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.